Flavonoid bioconversion in Bifidobacterium pseudocatenulatum B7003: A potential probiotic strain for...
-
Upload
independent -
Category
Documents
-
view
4 -
download
0
Transcript of Flavonoid bioconversion in Bifidobacterium pseudocatenulatum B7003: A potential probiotic strain for...
J O U R N A L O F F U N C T I O N A L F O O D S x x x ( 2 0 1 4 ) x x x – x x x
.sc ienced i rec t .com
Avai lab le a t wwwScienceDirect
journal homepage: www.elsevier .com/ locate / j f f
Flavonoid bioconversion in Bifidobacteriumpseudocatenulatum B7003: A potential probioticstrain for functional food development
1756-4646/$ - see front matter � 2013 Elsevier Ltd. All rights reserved.http://dx.doi.org/10.1016/j.jff.2013.12.018
* Corresponding author. Address: Department of Agricultural Sciences, Alma Mater Studiorum-University of Bologna, vialeBologna I-40127, Italy. Tel.: +39 051 2096269; fax: +39 051 2096274.
E-mail address: [email protected] (D. Di Gioia).
Please cite this article in press as: Di Gioia, D. et al., Flavonoid bioconversion in Bifidobacterium pseudocatenulatum B7003: A potentiastrain for functional food development, Journal of Functional Foods (2014), http://dx.doi.org/10.1016/j.jff.2013.12.018
Diana Di Gioiaa,*, Erwin Strahsburgerb, Ana M. Lopez de Laceyc, Valeria Bregolaa,Ilaria Marottia, Irene Aloisioa, Bruno Biavati a, Giovanni Dinelli a
aDepartment of Agricultural Sciences, Alma Mater Studiorum-University of Bologna, viale Fanin 44, Bologna, ItalybFacultad de Recursos Naturales Renovables, Universidad Arturo Prat, Av. Arturo Prat 2120, Casilla 121, Iquique, ChilecInstituto del Frıo-ICTAN (CSIC), Jose Antonio Novais 10, 28040 Madrid, Spain
A R T I C L E I N F O A B S T R A C T
Article history:
Received 16 July 2013
Received in revised form
17 December 2013
Accepted 19 December 2013
Available online xxxx
Keywords:
Flavonoids
Bifidobacteria
Probiotics
Fermented milks
Soybean
Legumes
Flavonoids are plant derived compounds mainly present as O-glycosides. They are hydro-
lyzed by gut microbial enzymes to their aglycons, which represent the bioavailable and bio-
active form. In this work the capability of a Bifidobacterium strain (Bifidobacterium
pseudocatenulatum B7003) of being used as a probiotic starter culture to obtain fermented
legume milks with an increased concentration of flavonoids in their aglycone form was
studied. B7003 strain can effectively bioconvert glycosylated flavonoids while fermenting
soybean or common bean derived milks. Conversely, a strain used as negative control (Bifi-
dobacterium longum B7254) could grow on the milks but had low activity in flavonoid biocon-
version. B7003 strain possesses basic safety properties, the capability of adhering to gut
epithelial cells and showed resistance to simulated food processing conditions. Thus, B.
pseudocatenulatum B7003 complies well with a new vision of probiotics, which, beside ben-
efits deriving from gut transit, have additional functional properties, such as the high bio-
availability of flavonoids in their aglycone form.
� 2013 Elsevier Ltd. All rights reserved.
1. Introduction
Plants are dietary sources of a large number of phytochemi-
cals. Among them, flavonoids are a large group of secondary
metabolites derived from the phenylpropanoid pathway in
higher plants. They play an important role in plant defense
and nodulation mechanisms (Cooper, 2004; Subramanian,
Stacey, & Yu, 2007). Recently their importance as health-pro-
moting compounds in preventing hormone dependent can-
cers, cardiovascular disease, osteoporosis and menopausal
symptoms have been highlighted by many studies (Ali, Velas-
quez, Hansen, Mohamed, & Bhathena, 2005; Cogolludo et al.,
2007; Cornwell, Cohick, & Raskin, 2004; Di et al., 2008; Ki, Yeo,
& Yhun, 2003; Kottra & Daniel, 2007; Moore et al., 2007; Nagat-
a, 2010; Rossi, Amaretti, Roncaglia, Leonardi, & Raimondi,
2010). These molecules, distributed mainly in leguminous
plants, are naturally occurring estrogen-like compounds
found in seeds and seedlings of soybean (Glycine max L.) (1–
3 mg/g) and other beans such as common bean (Phaseolus vul-
garis L.) (0.2–0.8 mg/g) (Dinelli et al., 2006), contributing to the
intake of bioactive compounds in Asian and Mediterranean
diets, respectively.
Fanin 44,
l probiotic
2 J O U R N A L O F F U N C T I O N A L F O O D S x x x ( 2 0 1 4 ) x x x – x x x
Flavonoids are found in plant source mainly as O-glyco-
sides, mainly bound to glucose, but also to other sugars such
as galactose, rhamnose, arabinose and xylose. The O-b-glyco-
sidic bonds of flavonoids, including the isoflavone daidzin
(daidzein-7-O-b-D-glucopyranoside), genistin and glycitin, are
hydrolyzed in the gut mainly by microbial b-glycosidases to
their aglycons, daidzein, genistein and glycitein, respectively
(Day et al., 2000; Hur, Lay, Beger, Freeman, & Rafii, 2000; Schnei-
der & Blaut, 2000; Schneider, Schwiertz, Collins, & Blaut, 1999).
This bacterial transformation is essential for flavonoids’
absorption, bioavailability and functional properties (Jou, Tsai,
Tu, & Wu, 2013; Rossi et al., 2010). Several studies have de-
scribed the b-glucosidase activity of different groups of bacte-
ria, including Bifidobacteria and Lactobacillus strains (Chun
et al., 2007, 2008; Di Cagno et al., 2010; Otieno, Ashton, & Shah,
2006; Raimondi et al., 2009; Rekha & Vijayalakshmi, 2010; Steer,
Johnson, Gee, & Gibson, 2003), which are beneficial microor-
ganisms of the human gastrointestinal tract frequently used
as probiotics in several functional foods (Dore & Corthier,
2010; Granata, Brandi, Borsari, Gasbarri, & Di Gioia, 2012; Sar-
kar, 2013). These bacteria have been found to be active in the
biotransformation of flavonoid glycosides occurring in com-
mon bean seeds and seedlings, as well as in derived foods (Mar-
otti, Bonetti, Biavati, Catizone, & Dinelli, 2007; Otieno et al.,
2006; Raimondi et al., 2009; Rekha & Vijayalakshmi, 2010).
A number of fermented products derived from cow’s milk
contain probiotic bacteria, which are often directly involved
in the fermentation process. Conversely, fermented products
based on different substrates, such as soybean or other le-
gumes, have little applications in western countries although
they are widely diffused in eastern countries (Lee, Lo, & Pan,
2013). Legumes not only have a high protein content (20–
40%), but are also rich in other nutritional compounds, such
as carbohydrates, B-complex vitamins like thiamine, niacin
and minerals such as calcium, magnesium, zinc, iron and
phosphorous (Garg & Dahiya, 2003). Soymilk fermented by lac-
tic acid bacteria has good nutritional and healthy properties
(Marazza, LeBlanc, de Giori, & Garro, 2013; Molina, Medici, Font
de Valdez, & Taranto, 2012). Moreover, it is a good medium for
growing bifidobacteria, because it contains sugars that are fer-
mented by most member of this genus (Scalabrini, Rossi, Spet-
toli, & Matteuzzi, 1998). Conversely, no studies have been
focused on common bean derived milk.
Bifidobacterium pseudocatenulatum B7003 strain possesses
high b-glucosidase activity and the capability of converting
the flavonoids of Phaseulus vulgaris seeds and seedlings, such
as kaempferol 3-O-glucoside, daidzin, genistin and glycitin,
into their aglycone forms without further metabolization (Mar-
otti et al., 2007). Considering that B. pseudocatenulatum is one of
the most abundant bacterial species in the human intestinal
tract and that probiotic research aims at developing functional
food products able to modify the gut microbiota to a potentially
healthier one (Gaggia, Di Gioia, Baffoni, & Biavati, 2011; Sarkar,
2013), B7003 strain may affect flavonoid-based products
enriching their content in bioavailable aglycone forms and, at
the same time, beneficially affecting the gut.
The main objective of the present contribution was to
investigate potential applications of B. pseudocatenulatum
Please cite this article in press as: Di Gioia, D. et al., Flavonoid bioconversiostrain for functional food development, Journal of Functional Foods (2014
B7003 strain as a probiotic starter culture to obtain fermented
legume milks with an increased concentration of bioavailable
flavonoids in their aglycone form. Probiotic characteristics
were studied in term of survival in simulated gastrointestinal
(GI) tract conditions and presence of antibiotic resistances.
Moreover, survival in food processing conditions was
evaluated.
2. Methods and materials
2.1. Chemicals
Reagents for culture media preparation and man rogosa sharpe
(MRS) broth were from Oxoid (Basingstoke, UK); anaerobic con-
ditions were obtained with an anaerobic atmosphere genera-
tion system (Anaerocult A, Merck, Darmstadt, Germany). All
solvents used for high-performance liquid chromatography
(HPLC) separation were HPLC grade from Carlo Erba, Milan.
For b-glucosidase activity the substrate (p-nitrophenyl-b-
glucopiranoside) and the product (p-nitrophenol) were from
Sigma–Aldrich, Milan (Italy). Authentic standards of kaempfer-
ol 3-O-glucoside and kaempferol were purchased from Indo-
fine Co. (Hillsborough, NJ). Isoflavone glycosides (daidzin,
genistin and glycitin) and related aglycones (daidzein, geni-
stein and glycitein) were from Extrasynthese (Genay, France).
2.2. Strain and culture conditions
B. pseudocatelunatum B7003 strain used in the study was cho-
sen considering its high capability of bioconverting glycosyl-
ated flavonoids into their aglycone forms in extracts
obtained from common bean seed and seedlings (Marotti
et al., 2007). Bifidobacterium longum B7254, which was found
not to possess detectable b-glucosidase activity, was selected
as the negative control. Strains were activated by two succes-
sive transfers in trypticase phytone yeast extract (TPY) med-
ium (Santini et al., 2010). An inoculum of 5% (v/v) was used
for strain cultivation, and incubation was carried out anaero-
bically at 37 �C for 24 h (Santini et al., 2010). Viable cell counts
were determined in triplicate by using the standard plate
counts on TPY agar and were expressed as colony-forming
units per milliliter of culture (CFU/mL).
2.3. Preparation and fermentation of soy and bean derivedmilk and fermentation of commercial soymilk
P. vulgaris L. seeds of the cultivar ‘‘Verdone’’ were purchased
from the seed producer Melandri Gaudenzio, Ravenna, Italy.
The seeds of P. vulgaris L. landrace ‘‘Zolfino del Pratomagno’’
were directly obtained from local farmers (Reggello, Arezzo,
Italy). One soybean (Glycine max L.) cultivar ‘‘Aires’’ was also
included in the study. Whole seeds of soybean and common
bean were washed and soaked in distilled water. After decant-
ing the water, they were crumbled in a blender using distilled
water (1:6% w/v). The resultant slurry was filtered with seven
layers of cheese cloth to obtain soymilk or beanmilk. In addi-
tion, a commercial soymilk (Valsoia) was used in fermenta-
tion studies.
n in Bifidobacterium pseudocatenulatum B7003: A potential probiotic), http://dx.doi.org/10.1016/j.jff.2013.12.018
J O U R N A L O F F U N C T I O N A L F O O D S x x x ( 2 0 1 4 ) x x x – x x x 3
Fermentation was performed in tubes each containing
5.0 mL of medium. Three tubes for each sampling time were
prepared for each substrate used. The fermentation medium
was composed of: 4.45 mL of soymilk or beanmilk, 0.05 mL
of 50 mg/mL L-cystein and 0.5 mL of inoculum. The inoculum
was prepared with an overnight TPY culture, centrifuged and
suspended in PBS buffer in order to obtain an A600 of 0.4. Not
inoculated tubes were used as controls. Sampling times were
soon after inoculum (time 0), 9, 24, 48 and 72 h of incubation.
At each sampling time, 0.1 mL of the tube content was used
for cell count evaluation via standard plate counts on TPY
agar plates and the same amount was used for pH measure-
ment. The remaining medium was extracted to evaluate the
content of flavonoids.
2.4. Extraction and HPLC analyses
Sep-Pak C18 cartridges (Agilent technologies, Milan, Italy)
were activated by 3 mL of ethyl acetate, 3 mL of methanol
and 3 mL of water. Each supernatant obtained from bacterial
culture fermentation was added to the column, and eluted
with 2 mL of ethyl acetate to collect the metabolites for HPLC
analysis. Each extract was vacuum-dried, dissolved in 0.5 mL
of 80% methanol solutions, and stored at �20 �C until analy-
sis. Flavonoids were analyzed by HPLC-DAD (Beckman) fol-
lowing the protocol of Marotti et al. (2007).
2.5. Survival in simulated GI tract conditions andadhesion to intestinal epithelial cell lines
The survival assays were performed with an overnight culture
of strain B7003 in TPY medium (A600 of about 0.9). Cells were
centrifuged, washed in PBS and suspended in the same buffer
to an A600 of 0.7 (corresponding to about 8.5 Log CFU/mL).
Resistance to acidity was evaluated by using PBS at different
pH values (2.5, 3.5 and 4.5); resistance to bile salts was exam-
ined preparing a PBS solution at pH 7.0 with 1 and 2% bile
salts (Ox-bile LP0055, Oxoid). The suspensions were incubated
anerobically at 37 �C and enumerated after 0, 0.5, 1 and 4 h. A
cell suspension at pH 4.5 was also maintained for 1 week at
4 �C in anaerobic conditions and cell survival was evaluated.
Adhesion to small intestinal human epithelial H4 cell
monolayers was performed as described in Aloisio et al.
(2012). Briefly, B. pseudocatenulatum B7003 was applied to H4
cell monolayers (prepared according to Aloisio et al. (2012))
at a concentration of 9.4 Log (CFU/m2). Results of attached
bacteria cells were expressed as percentage of adherent bac-
terial cells compared to initial inoculum and results were
compared with those obtained with the well known probiotics
strain LGG (Lactobacillus rhamnosus GG).
2.6. Survival to simulated food processing conditions
The strain resistance to starvation was examinated in PBS pH
7; resistance to thermal stresses was studied in PBS pH 7
pre-heated at 50 or 55 �C; resistance to osmotic pressure
was studied in PBS pH 7 with 2 and 4% NaCl. Cell suspensions,
prepared as described above, were incubated anerobically at
37 �C or at the desired temperature for thermal stresses and
enumerated after 0.5, 1 and 4 h of exposure. Viable cells were
Please cite this article in press as: Di Gioia, D. et al., Flavonoid bioconversistrain for functional food development, Journal of Functional Foods (2014
determined analyzing 100 lL of each culture with the micro-
dot methods (Strahsburger, Baeza, Monasterio, & Lagos,
2005) on TPY agar plates and cultured anaerobically at 37 �C.
2.7. Antibiotic resistance characterization
The following antibiotic agents, all suggested in the European
Food Safety Authority (EFSA) guidelines (EFSA, 2008), were
used: ampicillin, cefuroxime and vancomycin, as cell wall syn-
thesis inhibitor; chloramphenicol, erythromycin, kanamycin,
streptomycin and tetracycline as protein synthesis inhibitors.
All antibiotics were obtained from Sigma (St. Louis, MO, USA).
The procedure used for minimal inhibitory concentration
(MIC) has been described in Aloisio et al. (2012). Briefly, TPY
broth containing antibiotics at different concentrations (0.5–
500 lg/mL) was prepared and introduced in the wells of a mi-
cro-well plate. The inoculum for the wells was adjusted to a
concentration of 5 · 105 CFU/mL. The experiments were repli-
cated at least three times. The characterization of sensitivity/
resistance was done according to the guidelines and break-
points defined by EFSA (EFSA, 2008).
The presence of known antibiotic resistance genes was
checked via PCR using specific primers: aph (300)-I, aph (300)-
II, aph (300)-III coding for kanamycin and neomicine resistance
(Ouoba, Lei, & Jensen, 2008), aadA, aadE, ermA, streptomycin
and erythromycin-resistance genes (Ouoba et al., 2008), tet(M),
tet(O), tet(W) coding for tetracycline resistance (Masco, Van
Hoorde, De Brandt, Swings, & Huys, 2006) and blaCTX-M-g1,
blaCTX-M-g2, ß-lactam resistance (Van Hoek & Aarts, 2008).
The amplification conditions are from Ouoba et al. (2008).
The annealing temperature varied in the range 45–64 �C,
depending on the primer. Lactobacillus casei L9 was used as po-
sitive control for aph(300)-III, aadA, aadE genes whereas Bifido-
bacterium adolescentis DSM 20087 was the positive control for
tet(W) gene. PCR products were separated by electrophoresis
on 1.5% agarose gel.
Plasmid content in the B7003 strain was checked as de-
scribed in Aloisio et al. (2012).
2.8. Experimental design and statistical analysis
For the different trials, the adopted experimental scheme was
a fully randomized design. All the tests were performed in
triplicate. Data on glycoside flavonoid conversion, survival to
simulated gastrointestinal tract and industrial processing con-
ditions, antibiotic susceptibility were subjected to one-way
analysis of variance (ANOVA) by using the GLM procedure of
the SAS statistical package. Means were subjected to Fisher’s
test (SAS 1988). When treatments were significant according
to Fisher’s test, corresponding means were differentiated by
the SNK multiple range test at the 0.05 level of probability.
3. Results and discussion
3.1. Fermentation of soymilks and bean derived milks
The capability of B. pseudocatenulatum B7003 and of B. longum
B7254 strains of growing on a commercial soy milk, a soymilk
prepared with the cultivar Aires and two bean derived milks
on in Bifidobacterium pseudocatenulatum B7003: A potential probiotic), http://dx.doi.org/10.1016/j.jff.2013.12.018
4 J O U R N A L O F F U N C T I O N A L F O O D S x x x ( 2 0 1 4 ) x x x – x x x
was evaluated. Previous studies have shown that the capabil-
ity of Bifidobacterium spp. to grow on soymilks is not a specie-
specific feature and depends on the strain (Tsangalis, Ashton,
McGill, & Shah, 2002). B. pseudocatenulatum strains have never
been assayed for this purpose. Viable counts of the two Bifido-
bacterium strains in the commercial and Aires-derived soy-
milk is shown in Fig. 1 in comparison with growth on TPY
broth. B7003 strain could grow effectively in soymilks: expo-
nential growth on the commercial soymilk was observed over
the 1st and 9th h of incubation, reaching a 3 Log increase in
this time. Growth on soya Aires milk was of less extent (a 2
Log increase was observed over the 1st and 24th h of incuba-
tion) but, however, it was comparable to that on TPY medium.
Subsequently, viable counts on all soymilks rapidly de-
creased. The fast cell death may indicate a diminishing con-
centration of fermentable substrates, as already evidenced
in the works of Tsangalis et al. (2002). pH was 7.5 and 6.8 at
the beginning of the fermentation in the commercial soymilk
and in the milk from soya cultivar Aires, respectively, and
reached a value of 4.5 in both samples after 24 h in the com-
mercial milk and between 24 and 48 h for the soya Aires milk.
This drop in pH, determined by acid metabolites production
by Bifidobacterium strains, caused soymilk coagulation as incu-
bation proceeded. Results reported in the following sections
of this contribution showed a good capability of the B7003
strain of surviving at pH 4.5; therefore, on the whole, the data
obtained indicated 12 and 24 h as the optimal fermentation
times with no pH control for the commercial soymilk and
the milk from soya cultivar Aires, respectively. B. longum
B7254 strain evidenced a capability of growing on both soy-
milks similar to the B7003 strain (Fig. 1B), but the start of
growth on soymilks was slower.
Fig. 1 – Viable counts of B. pseudocatenulatum B7003 (A) and
B. longum B7254 (B) in the commercial (m) and Aires-derived
(h) soymilks in comparison with growth on TPY broth (s).
Please cite this article in press as: Di Gioia, D. et al., Flavonoid bioconversiostrain for functional food development, Journal of Functional Foods (2014
In addition, a new legume source for obtaining fermented
milks was assayed. B7003 strain showed a very good capabil-
ity of growing on the milks obtained from the two P. vulgaris
cultivars used (Fig. 2A). In the initial 24 h of incubation,
growth was even faster and of great extent with respect to
the TPY medium. As already observed for the soya Aires milk,
cell death was more rapid with respect to the TPY medium as
the incubation proceeded and a pH drop was observed. pH
reached the value of 4.0 both in the zolfino and in the verdone
milk between the 24th and 48th h of incubation. On the con-
trary, the B7254 strain had a limited growth on the two bean
milks (only 1 Log of cell increase after 24 h of incubation),
whereas growth on TPY was comparable to that of B7003
strain, Fig. 2B).
3.2. Glycoside flavonoid conversion in soymilks and beanderived milks
It is well known that flavonoids in fermented foods are more
available to humans than those present in non-fermented
products (Di Cagno et al., 2010). The ability of investigated bif-
idobacteria strains of converting isoflavone and kaempferol
glucosides into bioactive aglycones during soyamilk and
beanmilk fermentation was investigated (Table 1). HPLC anal-
yses showed that daizdin, genistin and glycitin, present in the
commercial soymilk and in the Aires derived milk, were con-
verted to the corresponding aglycones (didzein, genistein and
glycitein) with different rate constants (Table 2). According to
Eisen, Ungar, and Shimoni (2003) and Otieno et al. (2006), a
first order kinetics has been assumed to determine degrada-
tion constants for the individual isoflavone and kaempferol
glycosides. Plotting ln [C]/[C0] (where C is the concentration
Fig. 2 – Viable counts of B. pseudocatenulatum B7003 (A) and
B. longum B7254 (B) in the verdone (m) and zolfino (h)
beanmilks in comparison with growth on TPY broth (s).
n in Bifidobacterium pseudocatenulatum B7003: A potential probiotic), http://dx.doi.org/10.1016/j.jff.2013.12.018
Table 1 – Glycoside flavonoids and their aglyconic form in soymilks (commercial and Aires home-made soymilk) andbeanmilks (Verdone and Zolfino home-made beanmilks).
Source Glycoside flavonoids Aglycones
Valsoia (commercial soymilk) Daidzin Didzein
Genistin Genistein
Glycitin Glycitein
Aires (home-made soymilk) Daidzin Didzein
Daidzein malonyl
Genistin Genistein
Genistein malonyl
Glycitin Glycitein
Verdone (home-made beanmilk) Kaempferol 3-O-glucoside Kaempferol
Zolfino (home-made beanmilk) Kaempferol 3-O-glucoside Kaempferol
Table 2 – Flavonoids conversion in their aglyconic form in soymilks and bean derived milks according to first orderkinetics. C0 = initial concentration of the glycoside flavonoid expressed as lmol of flavonoid per gram of seed; K = rateconstant; R2 = coefficient of determination; P = statistical significance level (different letters indicate mean values differentat P < 0.05); CT50 = time (h) required for the conversion of 50% of the initial glycoside flavonoid into the respectiveaglycones and SD = Standard deviation of the CT50.
Glycoside flavonoid Source Strain C0 (lmol/g) K (h�1) R2 P CT50 (h) SD
Daidzin Valsoia B7003 6.518 0.207 0.998 c 3.4 0.1
Genistin Valsoia B7003 6.860 0.391 0.998 a 1.8 0.0
Glycitin Valsoia B7003 1.113 0.339 0.999 b 2.0 0.1
Daidzin Aires B7003 1.751 0.055 0.906 h 12.7 0.1
Genistin Aires B7003 1.641 0.149 0.821 e 4.6 0.0
Glycitin Aires B7003 0.242 0.176 0.990 d 4.0 0.4
Daidzin Valsoia B7254 6.518 0.036 0.892 ij 19.5 1.1
Genistin Valsoia B7254 6.860 0.082 0.851 g 8.4 0.5
Glycitin Valsoia B7254 1.113 0.023 0.949 jk 30.4 3.2
Daidzin Aires B7254 1.751 0.010 0.972 kl 68.7 2.9
Genistin Aires B7254 1.641 0.030 0.828 j 22.9 0.4
Glycitin Aires B7254 0.242 0.001 0.990 l 514.1 26.9
Daidzein malonyl Aires B7003 1.731 0.125 0.856 f 5.5 0.4
Genistein malonyl Aires B7003 1.549 0.149 0.911 e 4.7 0.6
Daidzein malonyl Aires B7254 1.731 0.001 0.828 l 1359.6 37.7
Genistein malonyl Aires B7254 1.549 0.000 0.818 l 1401.6 60.1
K 3-O-glucoside Verdone B7003 2.672 0.044 0.823 hi 15.6 0.8
K 3-O-glucoside Zolfino B7003 1.164 0.032 0.845 ij 21.5 0.1
K 3-O-glucoside Verdone B7254 2.672 0.003 0.814 l 252.1 10.5
K 3-O-glucoside Zolfino B7254 1.164 0.005 0.900 l 149.1 9.3
J O U R N A L O F F U N C T I O N A L F O O D S x x x ( 2 0 1 4 ) x x x – x x x 5
of the glycoside flavonoid at a certain time, and C0 is the ini-
tial concentration of the glycoside flavonoid) against time, in
accordance with a first order kinetic straight lines have been
obtained, as evidenced by the observed coefficients of deter-
mination (R2), ranging between 0.814 and 0.998 (Table 2).
With regards to isoflavones, the B7003 strain exhibited a
significantly higher b-glucosidase activity with respect to
B7254 strain (Table 2). Considering the soy milk source and
the type of glycoside isoflavone, the mean rate constant was
0.219 ± 0.128 and 0.030 ± 0.03 h�1 for the B7003 and B7254
strain, respectively. For the B7003 strain the 50% conversion
time (CT50) of different glycoside isoflavones into the respec-
tive aglycones ranged between 1.8 and 12.7 h, while for the
B7254 the same conversion required a time ranging between
Please cite this article in press as: Di Gioia, D. et al., Flavonoid bioconversistrain for functional food development, Journal of Functional Foods (2014
8.4 and 514.1 h. The b-glucosidase activity of both bifidobacte-
ria strains was strongly dependent on the preparation of soy
milk: a relatively slow conversion was observed for the Aires
home-made soy milk (total mean rate constant equal to
0.07 ± 0.07 h�1) with respect to commercial Valsoia prepara-
tion (total mean rate constant equal to 0.180 ± 0.158 h�1).
The observed matrix effect is presumably associated with
the different purity and contaminant level between home-
made and commercial soybean milk, affecting the enzymatic
activities of bifidobacteria strains. B7003 and B7254 strain
exhibited a similar affinity in converting different glycoside
isoflavones: the highest conversion was observed for genistin
(mean rate constants equal to 0.237 ± 0.212 and 0.09 ± 0.08 h�1
for B7002 and B7254 strain, respectively), while the lowest
on in Bifidobacterium pseudocatenulatum B7003: A potential probiotic), http://dx.doi.org/10.1016/j.jff.2013.12.018
6 J O U R N A L O F F U N C T I O N A L F O O D S x x x ( 2 0 1 4 ) x x x – x x x
b-glucosidase activity is referred to daidzin (mean rate con-
stant equal to 0.121 ± 0121 and 0.032 ± 0.031 h�1 for B7003
and B7254 strain, respectively). Glycitin showed an intermedi-
ate conversion rate with values more similar to those ob-
served for genistin (mean rate constants equal to
0.181 ± 0.222 and 0.088 ± 0.123 h�1 for B7003 and B7254 strain,
respectively).
Isoflavone malonyl forms (i.e., daidzein malonyl and geni-
stein malonyl) have been exclusively found in the Aires
home-made soy milk. The affinity of B7254 strain for malonyl
isoflavones was particularly low, as evidenced by the respec-
tive mean rate constants and CT50 values, ranging between
1359 and 1401 h. In contrast, B7003 strain has converted mal-
onyl forms with the same extent observed for the glycoside
isoflavones (Table 2).
The two bifidobacteria strains showed significant differ-
ences in converting kaempferol 3-O-glucoside. The B7003
strain converted 50% of this flavonoid into its respective agly-
cone form in less than one hour (total mean rate equal to
0.038 ± 0.008 h�1), while for B7254 the same conversion re-
quired a time ranging from 149 to 252 h (total mean rate
0.004 ± 0.001 h�1). The b-glucosidase activity of both bifido-
bacteria strains was independent of the source of kaempferol
3-O-glucoside (i.e., bean milk from Verdone or Zolfino bean).
3.3. Characterization of B7003 strain as a potentialprobiotic
3.3.1. Survival in simulated gastro-intestinal tract conditionsand adhesion to epithelial cellsThe ability of a potential probiotic strain to survive to the
transit in the gastrointestinal tract of the consumer (low pH
of the stomach and bile in the upper small intestine) and ad-
here to the gut epithelium is extremely important (Sheehan,
Sleator, Hill, & Fitzgerald, 2007). Cell suspension of B. pseudo-
catenulatum B7003 with 1% and 2% bile salts conserved the ini-
tial population for 2 h, decaying only 1 log after 4 h exposure
at both concentrations assayed (Table 3). Gastric pH (i.e., low-
er than 3) strongly affected the viability of B7003 strain, which
is a frequent feature in Bifidobacterium spp. strains (Dunne
et al., 1999; Santini et al., 2010); however, it is known that a
proper choice of the food carrier, such as a food matrix, for
the probiotic strain may enhance its survival in the stomach
due to the local increase of pH (Clegg & Shafat, 2010). There-
fore, the capability of the B7003 strain of surviving to slightly
higher pH with respect to the stomach one such as 3.5 and 4.5
is extremely important for its survival during the stomach
transit within a food matrix. In addition, as already pointed
Table 3 – Survival of B. pseudocatenulatum B7003 to simulatewith respect to time 0).
Time (hours) Survival percentage
pH 4.5 pH 3.5
0.5 100 100
1 97.2 95.8
4 95.8 62.5
Please cite this article in press as: Di Gioia, D. et al., Flavonoid bioconversiostrain for functional food development, Journal of Functional Foods (2014
out, survival at pH 4.5 is important considering that several
fermented milks can have an acidic pH at the end of the fer-
mentation process (Wang, Yu, & Chou, 2002); the survival
after 1 and 4 h exposure to these pH values is almost com-
plete (Table 3). A cell suspension of B7003 was also main-
tained at pH 4.5 for 1 week at 4 �C in anaerobic condition
and the survival was found to be 80% of the initial cell
amount, thus indicating a high survival in acidic pH at storage
conditions (data not shown).
The B7003 strain also showed a good ability to in vitro ad-
here to epithelial H4 cells, which was even higher with re-
spect to the LGG strain: 9.1 and 8.8 Log(CFU/m2) cells were
recovered after the adhesion test in the B7003 and LGG as-
says, respectively, out of the 9.4 Log(CFU/m2) cells initially ap-
plied. The ability of a potential probiotics strain to adhere to
the intestinal epithelium is a very important features as it al-
lows to persist in the gut preventing its elimination by peri-
stalsis and the adhesion of pathogenic bacteria.
3.3.2. Survival to simulated food processing conditionsThe potential of the B7003 strain of surviving to simulated
food processing conditions (starvation, reduced water activity
and thermal stresses) were also assayed and results are pre-
sented in Table 4. The strain was able to resist well to starva-
tion stress, maintaining almost all the initial population after
24 h of suspension in PBS, it was viable at 50 and 55 �C for 1 h
after the application of the thermal stress, decaying only 2 log
of the initial cell population. After 4 h of incubation, no cells
survived to both temperature stresses. However, considering
that bifidobacteria are generally sensitive to high temperature
(Schmidt & Zink, 2000), the tolerance of B7003 to 1 h exposure
to such high temperatures is of great significance; it is in fact
known that transient contacts with high temperatures can
occur during microorganism drying and storage processes in
the food industry (Meng, Stanton, Fitzgerald, Daly, & Ross,
2008; Simpson, Stanton, Fitzgerald, & Ross, 2005). The addi-
tion of 2% and 4% NaCl to increase the osmotic pressure only
slightly affected survival after 24 h of incubation.
3.3.3. Haemolysis and antibiotic resistanceStrain B7003 did not show any haemolytic activity on blood
agar plate (data not shown), in agreement with other studies
showing that haemolysis is rarely present in bifidobacteria
(Meile, Le Blay, & Thierry, 2008). Resistance or sensitivity to
the selected antibiotics and the relative MIC values obtained
are shown in Table 5; according to the FEEDAP 2008 guidelines
(EFSA, 2008), the strain was sensitive to Erythromycin, Vanco-
mycin and Chloramphenicol. It also showed a low MIC value
d GI tract conditions (expressed as percentage of survival
pH 2.5 Bile salts 1% Bile salts 2%
30 100 100
0 96.5 97.5
0 81.2 75.9
n in Bifidobacterium pseudocatenulatum B7003: A potential probiotic), http://dx.doi.org/10.1016/j.jff.2013.12.018
Table 4 – Survival of B. pseudocatenulatum B7003 to simulated industrial processing conditions (expressed as percentageof survival with respect to time 0).
Time (hours) Survival percentage
Starvation Thermal stress (50 �C) Thermal stress (55 �C) NaCl 2% NaCl 4%
0.5 100 65.3 65.5 100 100
1 100 65.3 63.1 100 100
4 100 0 0 100 100
24 95.3 –* –* 91.8 88.2
* – Not determined.
Table 5 – MIC of various antibiotics of B. pseudocatenul-atum B7003 strain. Strain are characterized as sensitiveor resistance according to the breakpoints defined by theEFSA (2008) guidelines.
Antibiotics MIC (mg/ml) Susceptibility
Ampicillin >500 Resistant
Kanamycin >500 Resistant
Streptomycin >500 Resistant
Tetracycline 16 Resistant
Erythromycin 1 Sensitive
Vancomycin 1 Sensitive
Chloranmphenicol 0.5 Sensitive
Cefuroxime 0.5 Sensitive*
* The breakpoint of cefuroxime is not defined in the EFSA guidelines,
the strain has been considered sensitive because of the low MIC.
J O U R N A L O F F U N C T I O N A L F O O D S x x x ( 2 0 1 4 ) x x x – x x x 7
to Cefuroxime, for which the antibiotic resistance breakpoint
is not available in the EFSA guidelines. On the contrary, the
strain was resistant to tetracycline, kanamycin, streptomycin
and ampicillin. Although tetracycline, kanamycin and strep-
tomycin resistances are widely diffused among bifidobacteria
(Ammor, Florez, Alvarez-Martın, Margolles, & Mayo, 2008;
D’Aimmo et al., 2007; Kiwaki & Sato, 2009), the genetic mech-
anism of antibiotic resistance in bifidobacteria has not been
completely elucidated and only some genes coding for tetra-
cycline resistance, such as tet(W) and tet(M), have been widely
characterized in Bifidobacterium spp. strains (Aires, Doucet-
Populaire, & Butel, 2007; Ammor et al., 2008; Meile et al.,
2008). Screening for resistance genes towards antibiotics to
which B7003 was resistant was performed with the use of
specific primers (detailed in Section 2). The only positive reac-
tion was found with tet(W), which is the most widely distrib-
uted tetracycline resistance gene among Bifidobacterium spp.
(Aires et al., 2007), whereas no amplification was obtained
with the primers specific for aph(300)III, aadE, blaCTX-M1 and
blaCTX-M2. The aph(300)III gene, coding for kanamycin resis-
tance, has been evidenced in Lactobacillus strains, but never
among bifidobacteria (Ouoba, Lei, & Jensen, 2008), whereas
the streptomycin resistance gene aadE has been evidenced
in a B. longum strain (Ouoba et al., 2008). In addition, the
search for b-lactam antibiotic resistance with the blaCTX-M1
and blaCTX-M2 specific primers, which were used to detect
this resistance in Enterobacteriaceae (Van Hoek & Aarts,
2008), had no success, although the blaCTX-M-g1 is quite dif-
fused among bifidobacteria (Aloisio et al., 2012). No plasmids
were detected in the B7003 strain and this represent an
Please cite this article in press as: Di Gioia, D. et al., Flavonoid bioconversistrain for functional food development, Journal of Functional Foods (2014
important feature considering that transmissible antibiotic
resistances are in the majority of strains encoded by plasmid
DNA. Therefore, the strain considered possess multiple resis-
tances to antibiotics, but they are all chromosomally encoded
and, therefore, their spread to other bacteria can be consid-
ered a rare event.
4. Conclusion
B. pseudocatenulatum B7003 strain has a great potential for
being used as a starter culture for the fermentation of legume
derived milks with increased functional properties. This
strain is capable of effectively bioconverting glycosylated
flavonoids to the aglycone forms while fermenting soya and
bean derived milks, thus improving their bioavailability. On
the contrary, B. longum B7254 strain can grow on the milks
but has a low activity in glycosylated flavonoid bioconversion.
Therefore, the choice of the strain for flavonoid bioconversion
is fundamental. In addition to the bioconversion activity, the
B7003 strain has interesting probiotic characteristics, as it
possesses basic safety properties, the capability of adhering
to gut epithelial cells and a high resistance in simulated food
processing conditions. In conclusion, the B. pseudocatenulatum
B7003 strain complies well with a new vision of probiotic
strains, which, beside traditional benefits deriving from their
transit in the gut, may have additional functional properties
for the consumers, such as the high availability of flavonoids
in their aglycone form. These properties can be exploited in
the development of functional foods containing probiotic
strains. Last but not least, this work has shown the potential
of other legumes different from soya beans of becoming inter-
esting ingredients for functional fermented products.
Acknowledgments
The study was funded by the University of Bologna, RFO Pro-
gram number J61J10000790001. Erwin Strahsburger received a
scholarship within the Erasmus Mundus Program. Ana M. Lo-
pez de Lacey received a fellowship within the JAE-CSIC pre-
doctoral Programme.
R E F E R E N C E S
Aires, J., Doucet-Populaire, F., & Butel, M. J. (2007). Tetracyclineresistance mediated by tet(W), tet(M) and tet(O) genes of
on in Bifidobacterium pseudocatenulatum B7003: A potential probiotic), http://dx.doi.org/10.1016/j.jff.2013.12.018
8 J O U R N A L O F F U N C T I O N A L F O O D S x x x ( 2 0 1 4 ) x x x – x x x
Bifidobacterium species from human isolates. Applied andEnvironment Microbiology, 73, 2751–2754.
Ali, A. A., Velasquez, M. T., Hansen, C. T., Mohamed, A. I., &Bhathena, S. J. (2005). Modulation of carbohydrate metabolismand peptide hormones by soybean isoflavones and probioticsin obesity and diabetes. Journal of Nutritional Biochemistry, 16,693–699.
Aloisio, I., Santini, C., Biavati, B., Dinelli, G., Cencic, A., Chingwaru,W., Mogna, L., & Di Gioia, D. (2012). Characterization ofBifidobacterium spp. strains for the treatment of entericdisorders in newborns. Applied Microbiology and Biotechnology,96, 1561–1576.
Ammor, M. S., Florez, A. B., Alvarez-Martın, P., Margolles, A., &Mayo, B. (2008). Analysis of tetracycline resistance tet(W) genesand their flanking sequences in intestinal Bifidobacteriumspecies. Journal of Antimicrobial Chemotherapy, 62, 688–693.
Chun, J., Jeong, W. J., Kim, J. S., Lim, J., Park, C. S., Kwon, D. Y., Choi,I., & Kim, J. H. (2008). Hydrolysis of isoflavone glucosides insoymilk fermented with single or mixed cultures ofLactobacillus paraplantarum KM, Weissella sp. 33, andEnterococcus faecium 35 isolated from humans. Journal ofMicrobiology and Biotechnology, 18, 573–578.
Chun, J., Kim, G. M., Lee, K. W., Choi, I. D., Kwon, G. H., Park, J. Y.,Jeong, S. J., Kim, J. S., & Kim, J. H. (2007). Conversion ofisoflavone glucosides to aglycones in soymilk by fermentationwith lactic acid bacteria. Journal of Food Science, 72, M39–M44.
Clegg, M., & Shafat, A. (2010). Gastric emptying and orocaecaltransit time of meals containing lactulose or inulin in men.British Journal of Nutrition, 104, 554–559.
Cogolludo, A., Frazziano, G., Briones, A. M., Cobeno, L., Moreno, L.,Lodi, F., Salaices, M., Tamargo, J., & Perez-Vizcaino, F. (2007).The dietary flavonoid quercetin activates BKCa currents incoronary arteries via production of H2O2. Role invasodilatation. Cardiovascular research, 73, 424–431.
Cooper, J. E. (2004). Multiple responses of rhizobia to flavonoidsduring legume root infection. Advances in Botanical Research, 41,1–62.
Cornwell, T., Cohick, W., & Raskin, I. (2004). Dietaryphytoestrogens and health. Phytochemistry, 65, 995–1016.
D’Aimmo, M. R., Modesto, M., & Biavati, B. (2007). Antibioticresistance of lactic acid bacteria and Bifidobacterium spp.isolated from dairy and pharmaceutical products. InternationalJournal of Food Microbiology, 115, 35–42.
Day, A. J., Canada, F. J., Dıaz, J. C., Kroon, P. A., McLauchlan, R.,Faulds, C. B., Plumb, G. W., Morgan, M. R. A., & Williamson, G.(2000). Dietary flavonoid and isoflavone glycosides arehydrolysed by the lactase site of lactase phlorizin hydrolase.FEBS Letters, 468, 166–170.
Di Cagno, R., Mazzacane, F., Rizzello, C. G., Vincentini, O., Silano,M., Giuliani, G., De Angelis, M., & Gobbetti, M. (2010). Synthesisof isoflavone aglycones and equol in soy milks fermented byfood-related lactic acid bacteria and their effect on humanintestinal caco-2 cells. Journal Agricultural Food Chemistry, 58,10338–10346.
Di, X., Yu, L., Moore, A. B., Castro, L., Zheng, X., Hermon, T., &Dixon, D. (2008). A low concentration of genistein inducesestrogen receptor-alpha and insulin-like growth factor-Ireceptor interactions and proliferation in uterine leiomyomacells. Human Reproduction, 23, 1873–1883.
Dinelli, G., Bonetti, A., Minelli, M., Marotti, I., Catizone, P., &Mazzanti, A. (2006). Content of flavonols in Italian bean(Phaseolus vulgaris L.) ecotypes. Food Chemistry, 99, 105–114.
Dore, J., & Corthier, G. (2010). The human intestinal microbiota.The intestinal microbiota: Equilibrium and Disorders, 34, S7–S15.
Dunne, C., Murphy, L., Flynn, S., O’Mahony, L., O’Halloran, S.,Feeney, M., Morrissey, D., Thornton, G., Fitzgerald, G., Daly, C.,Kiely, B., Quigley, E. M., O’Sullivan, G. C., Shanahan, F., &Collins, K. (1999). Probiotics: From myth to reality.
Please cite this article in press as: Di Gioia, D. et al., Flavonoid bioconversiostrain for functional food development, Journal of Functional Foods (2014
Demonstration of functionality in animal models of diseaseand in human clinical trials. Antonie Van Leeuwenhoek, 76,279–292.
EFSA. (2008). Opinion of the scientific panel on additives andproducts or substances used in animal feed on the updating ofthe criteria used in the assessment of bacteria for resistance toantibiotics of human or veterinary importance. EFSA Journal,223, 1–12.
Eisen, B., Ungar, Y., & Shimoni, E. (2003). Stability of isoflavones insoy milk stored at elevated and ambient temperatures. Journalof Agricultural and Food Chemistry, 51, 2212–2215.
Gaggia, F., Di Gioia, D., Baffoni, L., & Biavati, B. (2011). The role ofprotective and probiotic cultures in food and feed and theirimpact in food safety. Trends in Food Science and Technology, 22,58–66.
Garg, R., & Dahiya, S. (2003). Nutritional evaluation and shelf lifestudies of papads prepared from wheat-legume compositeflours. Plant Foods for Human Nutrition, 58, 299–307.
Granata, M., Brandi, G., Borsari, A., Gasbarri, R., & Di Gioia, D.(2012). Synbiotic yogurt consumption by healthy adults andthe elderly: The fate of bifidobacteria and LGG probiotic strain.International Journal of Food Sciences and Nutrition, 64, 162–168.
Hur, H. G., Lay, J. O., Jr., Beger, R. D., Freeman, J. P., & Rafii, F. (2000).Isolation of human intestinal bacteria metabolizing thenatural isoflavone glycosides daidzin and genistin. Archives ofMicrobiology, 174, 422–428.
Jou, H.-J., Tsai, P.-J., Tu, J.-H., & Wu, W.-H. (2013). Stinky tofu as arich source of bioavailable S-equol in Asian diets. Journal ofFunctional Foods, 5, 651–659.
Ki, E. J., Yeo, W. K., & Yhun, Y. S. (2003). Assessment of theestrogenicity of isoflavonoids, using MCF-7-ERE-Luc cells.Archives of Pharmaceutical Research, 26, 756–762.
Kiwaki, M., & Sato, T. (2009). Antimicrobial susceptibility ofBifidobacterium breve strains and genetic analysis ofstreptomycin resistance of probiotic B. breve strain Yakult.International Journal of Food Microbiology, 134, 211–215.
Kottra, G., & Daniel, H. (2007). Flavonoid glycosides are nottransported by the human Na +/glucose transporter whenexpressed in Xenopus laevis oocytes, but effectively inhibitelectrogenic glucose uptake. Journal of Pharmacology andExperimental Therapeutics, 322, 829–835.
Lee, B.-H., Lo, Y.-H., & Pan, T.-M. (2013). Anti-obesity activity ofLactobacillus fermented soy milk products. Journal of FunctionalFoods, 5, 905–913.
Marazza, J. A., LeBlanc, J. G., de Giori, G. S., & Garro, M. S. (2013).Soymilk fermented with Lactobacillus rhamnosus CRL981ameliorates hyperglycemia, lipid profiles and increasesantioxidant enzyme activities in diabetic mice. Journal ofFunctional Foods, 5, 1848–1853.
Marotti, I., Bonetti, A., Biavati, B., Catizone, P., & Dinelli, G. (2007).Biotransformation of common bean (Phaseolus vulgaris L.)flavonoid glycosides by Bifidobacterium species from humanintestinal origin. Journal of Agricultural and Food Chemistry, 55,3913–3919.
Masco, L., Van Hoorde, K., De Brandt, E., Swings, J., & Huys, G.(2006). Antimicrobial susceptibility of Bifidobacterium strainsfrom humans, animals and probiotic products. Journal ofAntimicrobial Chemotherapy, 58, 85–94.
Meile, L., Le Blay, G., & Thierry, A. (2008). Safety assessment ofdairy microorganisms: Propionibacterium and Bifidobacterium.International Journal of Food Microbiology, 126, 316–320.
Meng, X. C., Stanton, C., Fitzgerald, G. F., Daly, C., & Ross, R. P.(2008). Anhydrobiotics: The challenges of drying probioticcultures. Food Chemistry, 106, 1406–1416.
Molina, V., Medici, M., Font de Valdez, G., & Taranto, M. P. (2012).Soybean-based functional food with vitamin B12-producing lactic acid bacteria. Journal of Functional Foods,4, 831–836.
n in Bifidobacterium pseudocatenulatum B7003: A potential probiotic), http://dx.doi.org/10.1016/j.jff.2013.12.018
J O U R N A L O F F U N C T I O N A L F O O D S x x x ( 2 0 1 4 ) x x x – x x x 9
Moore, A. B., Castro, L., Yu, L., Zheng, X., Di, X., Sifre, M. I.,Kissling, G. E., Newbold, R. R., Bortner, C. D., & Dixon, D. (2007).Stimulatory and inhibitory effects of genistein on humanuterine leiomyoma cell proliferation are influenced by theconcentration. Human Reproduction, 22, 2623–2631.
Nagata, C. (2010). Factors to consider in the association betweensoy isoflavone intake and breast cancer risk. Journal ofEpidemiology, 20, 83–89.
Otieno, D. O., Ashton, J. F., & Shah, N. P. (2006). Evaluation ofenzymic potential for biotransformation of isoflavonephytoestrogen in soymilk by Bifidobacterium animalis,Lactobacillus acidophilus and Lactobacillus casei. Food ResearchInternational, 39, 394–407.
Ouoba, L., Lei, V., & Jensen, L. B. (2008). Resistance of potentialprobiotic lactic acid bacteria and bifidobacteria of African andEuropean origin to antimicrobials: Determination andtransferability of the resistance genes to other bacteria.International Journal of Food Microbiology, 121, 217–224.
Raimondi, S., Roncaglia, L., De Lucia, M., Amaretti, A., Leonardi,A., Pagnoni, U. M., & Rossi, M. (2009). Bioconversion of soyisoflavones daidzin and daidzein by Bifidobacterium strains.Applied Microbiology and Biotechnology, 81, 943–950.
Rekha, C. R., & Vijayalakshmi, G. (2010). Bioconversion ofisoflavone glycosides to aglycones, mineral bioavailability andvitamin B complex in fermented soymilk by probiotic bacteriaand yeast. Journal of Applied Microbiology, 109, 1198–1208.
Rossi, M., Amaretti, A., Roncaglia, L., Leonardi, A., & Raimondi, S.(2010). Dietary isoflavones and intestinal microbiota:Metabolism and transformation into bioactive compounds. InMelanie J. Thompson (Ed.), Isoflavones biosynthesis, occurrenceand health effects (pp. 137–161).
Santini, C., Baffoni, L., Gaggia, F., Granata, M., Gasbarri, R., & DiGioia, D. (2010). Characterization of probiotic strains: Anapplication as feed additives in poultry against Campylobacterjejuni. International Journal of Food Microbiology, 141, S98–S108.
Sarkar, S. (2013). Probiotics as functional foods: Documentedhealth benefits. Nutrition & Food Science, 43, 107–115.
Scalabrini, P., Rossi, M., Spettoli, P., & Matteuzzi, D. (1998).Characterization of Bifidobacterium strains for use in soymilkfermentation. International Journal of Food Microbiology, 39,213–219.
Please cite this article in press as: Di Gioia, D. et al., Flavonoid bioconversistrain for functional food development, Journal of Functional Foods (2014
Schmidt, G., & Zink, R. (2000). Basic features of the stress responsein three species of bifidobacteria: B. longum, B. adolescentis, andB. breve. International Journal of Food Microbiology, 55, 41–45.
Schneider, H., & Blaut, M. (2000). Anaerobic degradation offlavonoids by Eubacterium ramulus. Archives of Microbiology, 173,71–75.
Schneider, H., Schwiertz, A., Collins, M. D., & Blaut, M. (1999).Anaerobic transformation of quercetin-3-glucoside by bacteriafrom the human intestinal tract. Archives of Microbiology, 171,81–91.
Sheehan, V. M., Sleator, R. D., Hill, C., & Fitzgerald, G. F. (2007).Improving gastric transit, gastrointestinal persistence andtherapeutic efficacy of the probiotic strain Bifidobacterium breveUCC2003. Microbiology, 153, 3563–3571.
Simpson, P. J., Stanton, C., Fitzgerald, G. F., & Ross, R. P. (2005).Intrinsic tolerance of Bifidobacterium species to heat andoxygen and survival following spray drying and storage.Journal of Applied Microbiology, 99, 493–501.
Steer, T. E., Johnson, I. T., Gee, J. M., & Gibson, G. R. (2003).Metabolism of the soyabean isoflavone glycoside genistinin vitro by human gut bacteria and the effect of prebiotics.British Journal of Nutrition, 90, 635–642.
Strahsburger, E., Baeza, M., Monasterio, O., & Lagos, R. (2005).Cooperative uptake of microcin E492 by receptors FepA, Fiu,and Cir and inhibition by the siderophore enterochelin and itsdimeric and trimeric hydrolysis products. Antimicrobial Agentsand Chemotherapy, 49, 3083–3086.
Subramanian, S., Stacey, G., & Yu, O. (2007). Distinct, crucial rolesof flavonoids during legume nodulation. Trends in Plant Science,12, 282–285.
Tsangalis, D., Ashton, J. F., McGill, A. E. J., & Shah, N. P. (2002).Enzymic transformation of isoflavone phytoestrogens insoymilk by b-glucosidase-producing bifidobacteria. Journal ofFood Science, 67, 3104–3113.
Van Hoek, A. H. A., & Aarts, H. J. M. (2008). Microarray baseddetection of antibiotic resistance genes in Salmonella. FoodAnalytical Methods, 1, 95–108.
Wang, Y.-C., Yu, R.-C., & Chou, C.-C. (2002). Growth and survival ofbifidobacteria and lactic acid bacteria during the fermentationand storage of cultured soymilk drinks. Food Microbiology, 19,501–508.
on in Bifidobacterium pseudocatenulatum B7003: A potential probiotic), http://dx.doi.org/10.1016/j.jff.2013.12.018